GOSS Earnings

Quarterly EPS
$-11.66
Q4 2024
$-12.80
Q1 2025
$-13.60
Q2 2025
$-16.92
Q3 2025
$-16.29
Q4 2025
$-16.00
Q1 2026
$4.00
Q2 2026
$-7.36
Q3 2026
Latest Revenue38.4M
Latest Net Income-48072000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q3 2026-$7.3638.4M-48072000+189.1%+56.5%
Q2 2026$4.009.2M16.9M-19.6%+129.4%
Q1 2026-$16.0017.0M-46664000+71.5%-25.0%
Q4 2025-$16.2913.8M-47238000+47.1%-39.7%
Q3 2025-$16.9213.3M-48221000+40.2%-51.1%
Q2 2025-$13.6011.5M-38273000-88.0%-177.3%
Q1 2025-$12.809.9M-36638000—+15.8%
Q4 2024-$11.669.4M-33029000—+31.2%
Q3 2024-$11.209.5M-30803000——
Q2 2024$17.6095.8M49.2M——
Q1 2024-$15.200-41928000——
Q4 2023-$16.950-48148000——
Gossamer Bio (GOSS) — Earnings